AJOVY (Teva Pharma Australia Pty Ltd)
Product name
AJOVY
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
202 working days (255)
Active ingredients
fremanezumab
Registration type
NCE/NBE
Indication
AJOVY (solution for injection) is indicated for the preventive treatment of migraine in adults.